Incidence of Atrial Fibrillation in Patients With Severe Obstructive Sleep Apnea: The Reveal XT-SA Study

Exclusion Criteria

• •1. Previous history of clinical AF defined as documented lone, paroxysmal, persistent or permanent, according to standard definitions.
• •2. Patient with anticipated requirement of MRI.
• •3. Patient with well-know allergy to any component of the Medtronic Reveal XT.
• •4. Patients with implantable cardiac rhythm device \[pacemakers or internal cardiac device (ICDs)\].
• •5. Women of child bearing potential.
• •6. Unable or unwilling to provide written informed consent.
• •7. Unable or unwilling to complete the study follow-up schedule (eg. intention to leave the Kingston area over the next 3 years.
• •8. Previously enrolled in this trial.
• •9. Enrolled in another study that would confound the results of this trial.
• •10. Documented history of heart failure
• •11. Diagnosed with severe obstructive sleep apnea greater than 1 year from screening date